|The SERPINA1 serpina1 (Catalog #MBS653849) is an Enzyme produced from Pooled human serum or plasma and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s a1-Antichymotrypsin can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA).
Suitable for use in ELISA. Researchers should empirically determine the suitability of the SERPINA1 serpina1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The SERPINA1 serpina1 product has the following accession number(s) (GI #189163542) (NCBI Accession #NP_001121179.1) (Uniprot Accession #P01009). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Alpha1-Antichymotrypsin (AACT) is a serine proteinase inhibitor and minor acute phase protein with a molecular weight of ~68kD, occurring in serum at 250-500mg/l. AACT appears to inhibit chymotrypsin specifically.
Blood, Bone, Heart, Intestine, Kidney, Liver, Lung, Pancreas, Skin, Vascular tissues are correlated with this protein. The following patways have been known to be associated with this gene. Carcinoma, Hepatocellular, Cardiovascular Diseases, Inflammation, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Lung Diseases, Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema, alpha 1-Antitrypsin Deficiency are some of the diseases may be linked to a1-Antichymotrypsin, Human (AACT, Alpha1-ACT).